vs
Side-by-side financial comparison of FIRST COMMONWEALTH FINANCIAL CORP (FCF) and Vericel Corp (VCEL). Click either name above to swap in a different company.
FIRST COMMONWEALTH FINANCIAL CORP is the larger business by last-quarter revenue ($133.7M vs $92.9M, roughly 1.4× Vericel Corp). FIRST COMMONWEALTH FINANCIAL CORP runs the higher net margin — 28.1% vs 25.0%, a 3.1% gap on every dollar of revenue. On growth, Vericel Corp posted the faster year-over-year revenue change (23.3% vs 13.0%). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs 5.5%).
First Commonwealth Financial Corp is a Pennsylvania-based regional financial services holding company. It offers consumer and commercial banking products, loans, wealth management, and insurance services for individuals, small and mid-sized enterprises across central and western Pennsylvania and Ohio.
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
FCF vs VCEL — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $133.7M | $92.9M |
| Net Profit | $37.5M | $23.2M |
| Gross Margin | — | 78.7% |
| Operating Margin | — | 24.1% |
| Net Margin | 28.1% | 25.0% |
| Revenue YoY | 13.0% | 23.3% |
| Net Profit YoY | 14.8% | 17.3% |
| EPS (diluted) | $0.37 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $133.7M | — | ||
| Q4 25 | $137.9M | $92.9M | ||
| Q3 25 | $136.0M | $67.5M | ||
| Q2 25 | $131.0M | $63.2M | ||
| Q1 25 | $118.0M | $52.6M | ||
| Q4 24 | $120.4M | $75.4M | ||
| Q3 24 | $121.2M | $57.9M | ||
| Q2 24 | $120.2M | $52.7M |
| Q1 26 | $37.5M | — | ||
| Q4 25 | $44.9M | $23.2M | ||
| Q3 25 | $41.3M | $5.1M | ||
| Q2 25 | $33.4M | $-553.0K | ||
| Q1 25 | $32.7M | $-11.2M | ||
| Q4 24 | $35.8M | $19.8M | ||
| Q3 24 | $32.1M | $-901.0K | ||
| Q2 24 | $37.1M | $-4.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | 78.7% | ||
| Q3 25 | — | 73.5% | ||
| Q2 25 | — | 73.7% | ||
| Q1 25 | — | 69.0% | ||
| Q4 24 | — | 77.6% | ||
| Q3 24 | — | 71.9% | ||
| Q2 24 | — | 69.5% |
| Q1 26 | — | — | ||
| Q4 25 | 40.9% | 24.1% | ||
| Q3 25 | 38.1% | 5.1% | ||
| Q2 25 | 32.1% | -3.2% | ||
| Q1 25 | 34.8% | -24.3% | ||
| Q4 24 | 37.1% | 24.5% | ||
| Q3 24 | 33.4% | -4.3% | ||
| Q2 24 | 38.7% | -11.5% |
| Q1 26 | 28.1% | — | ||
| Q4 25 | 32.5% | 25.0% | ||
| Q3 25 | 30.4% | 7.5% | ||
| Q2 25 | 25.5% | -0.9% | ||
| Q1 25 | 27.7% | -21.4% | ||
| Q4 24 | 29.8% | 26.3% | ||
| Q3 24 | 26.5% | -1.6% | ||
| Q2 24 | 30.9% | -8.9% |
| Q1 26 | $0.37 | — | ||
| Q4 25 | $0.44 | $0.46 | ||
| Q3 25 | $0.39 | $0.10 | ||
| Q2 25 | $0.32 | $-0.01 | ||
| Q1 25 | $0.32 | $-0.23 | ||
| Q4 24 | $0.35 | $0.40 | ||
| Q3 24 | $0.31 | $-0.02 | ||
| Q2 24 | $0.36 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $137.5M |
| Total DebtLower is stronger | $154.9M | — |
| Stockholders' EquityBook value | $1.6B | $354.6M |
| Total Assets | $12.3B | $488.0M |
| Debt / EquityLower = less leverage | 0.10× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $137.5M | ||
| Q3 25 | — | $135.4M | ||
| Q2 25 | — | $116.9M | ||
| Q1 25 | — | $112.9M | ||
| Q4 24 | — | $116.2M | ||
| Q3 24 | — | $101.7M | ||
| Q2 24 | — | $102.5M |
| Q1 26 | $154.9M | — | ||
| Q4 25 | $261.7M | — | ||
| Q3 25 | $262.1M | — | ||
| Q2 25 | $262.4M | — | ||
| Q1 25 | $262.7M | — | ||
| Q4 24 | $263.0M | — | ||
| Q3 24 | $136.3M | — | ||
| Q2 24 | $136.6M | — |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $354.6M | ||
| Q3 25 | $1.5B | $321.9M | ||
| Q2 25 | $1.5B | $306.8M | ||
| Q1 25 | $1.4B | $295.5M | ||
| Q4 24 | $1.4B | $292.0M | ||
| Q3 24 | $1.4B | $257.5M | ||
| Q2 24 | $1.4B | $243.0M |
| Q1 26 | $12.3B | — | ||
| Q4 25 | $12.3B | $488.0M | ||
| Q3 25 | $12.3B | $453.3M | ||
| Q2 25 | $12.2B | $435.6M | ||
| Q1 25 | $11.8B | $424.6M | ||
| Q4 24 | $11.6B | $432.7M | ||
| Q3 24 | $12.0B | $390.4M | ||
| Q2 24 | $11.6B | $376.8M |
| Q1 26 | 0.10× | — | ||
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.17× | — | ||
| Q2 25 | 0.17× | — | ||
| Q1 25 | 0.18× | — | ||
| Q4 24 | 0.19× | — | ||
| Q3 24 | 0.10× | — | ||
| Q2 24 | 0.10× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $15.0M |
| Free Cash FlowOCF − Capex | — | $12.8M |
| FCF MarginFCF / Revenue | — | 13.8% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | — | 0.65× |
| TTM Free Cash FlowTrailing 4 quarters | — | $24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $187.5M | $15.0M | ||
| Q3 25 | $49.5M | $22.1M | ||
| Q2 25 | $30.4M | $8.2M | ||
| Q1 25 | $55.9M | $6.6M | ||
| Q4 24 | $129.5M | $22.2M | ||
| Q3 24 | $53.6M | $10.2M | ||
| Q2 24 | $22.7M | $18.5M |
| Q1 26 | — | — | ||
| Q4 25 | $171.5M | $12.8M | ||
| Q3 25 | — | $19.5M | ||
| Q2 25 | — | $81.0K | ||
| Q1 25 | — | $-7.6M | ||
| Q4 24 | $113.9M | $8.5M | ||
| Q3 24 | — | $-9.2M | ||
| Q2 24 | — | $1.8M |
| Q1 26 | — | — | ||
| Q4 25 | 124.3% | 13.8% | ||
| Q3 25 | — | 28.8% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | -14.5% | ||
| Q4 24 | 94.6% | 11.2% | ||
| Q3 24 | — | -15.9% | ||
| Q2 24 | — | 3.4% |
| Q1 26 | — | — | ||
| Q4 25 | 11.7% | 2.4% | ||
| Q3 25 | — | 3.9% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 27.0% | ||
| Q4 24 | 12.9% | 18.3% | ||
| Q3 24 | — | 33.5% | ||
| Q2 24 | — | 31.8% |
| Q1 26 | — | — | ||
| Q4 25 | 4.18× | 0.65× | ||
| Q3 25 | 1.20× | 4.35× | ||
| Q2 25 | 0.91× | — | ||
| Q1 25 | 1.71× | — | ||
| Q4 24 | 3.61× | 1.12× | ||
| Q3 24 | 1.67× | — | ||
| Q2 24 | 0.61× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FCF
Segment breakdown not available.
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
